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The number and shape of limb tendons vary along the proximodistal axis, and the autopod contains
more tendons than the zeugopod. The transcription factor Six2 is expressed in the developing tendons,
and its expression can be traced back to a group of limb mesenchymal cells that are thought to be tendon
precursor cells. We tried to elucidate the mechanism controlling position-speciﬁc tendon pattern
formation using Six2 as a tendon marker. Six2 expression was always found in cells between the limb
cartilage and ectoderm. Administration of BMP-2 or BMP antagonist Noggin to the limb bud, respectively
repressed or facilitated Six2 expression. Removal of the ectoderm or administration of the Wnt
antagonist sFRP-2 abolished Six2 expression and ectopic Wnt expression induced ectopic Six2 expres-
sion. Taken together, Six2 expression is induced in the cells located at the point where cartilage-derived
Noggin and ectoderm-derived Wnt signals meet. Misexpression of the autopod-speciﬁc Hoxa-13 or
Hoxd-13 induced ectopic expression of Six2 in the zeugopodal mesenchymal cells of the chick limb bud.
Six2 expression in the dorsal autopodal mesenchyme was not detected in Hoxa-13−/−;HoxDdel/del mice,
indicating that autopod-speciﬁc Hox is required for the regulation of Six2 expression. Misexpression of
Wnt in the autopod induced ectopic Six2 expression in the autopod. On the other hand, Wnt
misexpression alone never induced Six2 expression in the zeugopod, yet co-misexpression of Hoxa-13
and Wnt in the zeugopod enhanced ectopic Six2 expression. Our results indicate that autopodal Hox
genes regulate Six2 expression in the autopodal tendon precursor in cooperation with the factors from
cartilage and ectoderm.
& 2013 Elsevier Inc. All rights reserved.Introduction
During organogenesis, constituent tissues develop with ordered
spatiotemporal patterns and make physical and functional connec-
tions with each other. In this process, the tissues that form earlier
often play important roles in subsequent tissue patterning. In this
process, two distinct mechanisms would be essential. One is the
mechanism that determines the differentiation fate of the stem cells
or precursor cells based upon their relative position in the organ
primordium and upon the stage of organogenesis. The other is a
mechanism that controls position-speciﬁc morphologies through
control of cell proliferation, migration and adhesion.
The locomotor system of the limb consists of bone and muscle,
as well as the tendon and ligament that connect them physically
and functionally. These tissues have position-speciﬁc morpholo-
gies along the dorsoventral (D–V) and proximodistal (P–D) axes.
Bone develops from the cartilaginous primordium in the limb.
Cartilage, tendon, ligament, and fascia originate from the limbll rights reserved.mesenchyme. In contrast, the limb muscle is derived from muscle
mass, the cells migrating from the somites. These basic tissues
having different origins or different developmental timing coordi-
nately construct the functional locomotor system.
Among the mechanisms of pattern formation in mesenchyme-
derived tissues, those of cartilage are the best understood. Carti-
lage pattern formation takes place autonomously in the limb
mesenchyme under the control of a positional speciﬁcation system
consisting of the Hox genes. In the developing central nervous
system, somites, lateral plate mesoderm and digestive tract, Hox
genes are expressed sequentially along the anteroposterior (A–P)
axis according to their order in the Hox clusters, and the Hox code
determines positional speciﬁcity prior to position-speciﬁc tissue
formation (Krumlauf, 1994; Sakiyama et al., 2001; Yokouchi et al.,
1995b). In the limb mesenchyme, the Abd-B genes belonging to the
Hoxa or Hoxd cluster are expressed in a nested fashion along the
P–D or the A–P axes (Nelson et al., 2006; Yokouchi et al., 1991a).
Gain-of-function and loss-of-function of Hox genes result in
defective or altered skeletal patterns in the limb (Yokouchi et al.,
1995a; Goff and Tabin, 1997; Fromental-Ramain et al., 1996;
Zakany et al., 1997), indicating both unique and redundant func-
tions of each Hox gene. Positional speciﬁcation by the Hox code
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position-speciﬁc precartilaginous condensation pattern (Yokouchi
et al., 1995a).
In muscle development, sequential splitting of the migrating
muscle mass results in position-speciﬁc muscle pattern. Prior to
splitting, several Hox genes are expressed in the muscle mass in a
position-speciﬁc manner (Yamamoto et al., 1998), and Hox expres-
sion is regulated by interaction with the limb mesenchyme via
soluble signaling molecules (Hashimoto et al., 1999). Hox genes
then regulate gene expression that controls muscle differentiation
(Yamamoto and Kuroiwa, 2003).
Tendon and ligament connect cartilage and muscle or cartilage
and cartilage, respectively. For establishment of the correct posi-
tional relationships, coordination between precursor mesenchyme
and the earlier-formed tissues, such as cartilage and ectoderm, is
essential. A genetic system for tendon development was studied
using the transcription factor Scleraxis (Scx) as a marker. Scx
expression is induced around the muscle mass, extends distally
and elongates along the digits. For Scx expression, cartilage func-
tions via Noggin, a bone morphogenic protein (BMP) antagonist,
and limb ectoderm is essential (Schweitzer et al., 2001). However,
the ectodermal inductive factors have not yet been identiﬁed. At the
developmental stage when tendon connects the skeletal element
and muscle, Fgfs and Tgf-beta play crucial roles (Edom-Vovard et al.,
2001; Edom-Vovard et al., 2002; Pryce et al., 2009).
Tendons vary in number and morphology along the P–D axis of
the limb. In hindlimb, the tendons of zeugopodal muscles have
insertion sites on the distal autopodal skeletal elements. Although
they show very simple string-like morphologies in the zeugopod,
they intricately bifurcate in the autopod. In addition, many shorter
tendons of the metatarsal muscles, including the abductors, adduc-
tors, and extensors, also exist in the autopod (Baumel et al., 1993;
Greene, 1963). Therefore, there are more tendons, in number, in the
autopod than in the zeugopod. So it is possible that there is a unique
mechanism for autopodal tendon formation, and the best candidate
for involvement in this mechanism is the Hox system.
In the present study, we aimed to clarify the mechanisms of
position-speciﬁc tendon precursor formation in the limb. For this
purpose, we focused on the regulatory mechanisms of expression of
the tendon-related gene Six2. Six2 is a member of the Six (sine oculis-
related homeobox) gene family, which contains the vertebrate homo-
logues of the Drosophila eye gene sine oculis (Cheyette et al., 1994). A
previous report suggested that Six2 is a speciﬁc marker for the tendon
precursor and tendon in the mouse limb (Oliver et al., 1995). In this
report, we ﬁrst show that Six2 expression marks the tendon precursor
and tendon during chick limb development. Then we show regulation
of Six2 expression by Noggin from the cartilage and Wnts from the
ectoderm. Finally we show that Hoxa-13 and Hoxd-13, autopod-
speciﬁc Hox genes, regulate Six2 expression in the autopodal tendon
precursor in cooperation with cartilage- and ectoderm-derived factors.
Materials and methods
Mouse embryos
Mice mutant for Hoxa-13 (Fromental-Ramain et al., 1996) and
HoxDdel mice (Zakany et al., 1997) were provided by Dr. Pierre
Chambon (IGBMC) and Dr. Denis Duboule (Univ. of Geneva), respec-
tively. Hoxa-13−/−;HoxDdel/del embryos were obtained by the intercross
of Hoxa-13þ /−;HoxDþ /del double heterozygote mice. Genotyping was
carried out by PCR methods using yolk sac-derived DNA.
Chicken embryos
Fertilized chicken eggs were purchased from Gen Corporation
(Gifu, Japan) or Yamagishi farm (Mie, Japan). For genemisexpression using retroviral vectors, line-M White Leghorn eggs
were supplied by Nippon Institute for Biological Science (Kobuchi-
zawa, Japan). Eggs were incubated at 38.5 °C, and embryos were
staged according to Hamburger and Hamilton (1951).
Isolation of chicken Six2 cDNA
RT-PCR was performed using RNA isolated from St. 35 limbs. A
347 bp Six2 cDNA fragment was obtained by PCR using degenerate
primers designed based on the amino acid sequences conserved
between murine Six1 and Six2 proteins. To isolate cDNAs corre-
sponding to the 5′ and 3′ regions of Six2, 5′ RACE and 3′ RACE were
performed. The chicken Six2 cDNA sequence was deposited in
DDBJ (accession No.AB199732). See Suppl. Data for the sequence of
PCR primers.
RNA probes
Antisense riboprobes were labeled with digoxigenin or ﬂuor-
escein. For the chicken Six2 probe, the fragment corresponding to
position 638–941 of the DDBJ sequence (accession no. AB199732)
was isolated by PCR. For detection of endogenous chicken and
virally expressed Hoxa-13 mRNA, an RNA probe was synthesized
by using a cDNA clone (Yamamoto and Kuroiwa, 2003) or the SpeI-
BamHI fragment of this cDNA. A probe for endogenous Hoxa-13
alone was synthesized by using a 330 bp 3′ UTR fragment
ampliﬁed by PCR from a genomic clone (Yokouchi et al., 1991a).
Chicken Noggin, Bmp-7,Wnt3 and mouse Scx cDNA fragments were
isolated by PCR based on NCBI sequence data (Chicken Noggin,
Bmp-7 and mouse Scx) or chicken genome database sequences
(Chicken Wnt3). Mouse Noggin, Gremlin and Six2 genomic DNA
fragments were isolated by PCR. Chicken Scx was provided by
Dr. C. J. Tabin. Other probes were described previously: PG-H, LTR
(Yokouchi et al., 1995a), chicken Pax7 (Kawakami et al., 1997),
chicken Bmp-2 and Bmp-4 (Yokouchi et al., 1996), chicken Teno-
modulin (Shukunami et al., 2006) and chicken Hoxd-13 (Yokouchi
et al., 1991a).
In situ hybridization (ISH) and immunoﬂuorescence
Whole-mount in situ hybridization (WISH) was performed
following Dietrich et al. (1997), with minor modiﬁcations. Some
embryos were sectioned by vibratome after WISH. Section in situ
hybridization (SISH) was performed following Braissant and Wahli
(1998), with the following modiﬁcations: embryos were incubated
with PBS containing 30% sucrose at 4 °C overnight, embedded in O.
C.T. compound (Sakura Finetechnical Co. Ltd., Japan), frozen, and
sectioned at 10–20 µm thickness. The hybridization solution was
described previously (Harland, 1991). Prehybridization and hybri-
dization were carried out at 65 °C and 70 °C, respectively. For wash
steps, solution-X (Dietrich et al., 1997) was used instead of SSC.
Wash steps were performed at 70 °C. To detect Pax7 protein after
SISH, the Sigma Fast™ Fast Red TR/Naphthol AS-MX Tablet Set
(Sigma) was used for the color development reaction of SISH, and
mouse monoclonal anti-Pax7 IgG (DSHB) and biotinylated horse
anti-mouse IgG (Vector) were used as the ﬁrst and second anti-
body, respectively. Streptavidin, Alexa Fluor™ 488 conjugate
(Molecular Probes) was used for detection.Surgical manipulations
For ectopic cartilage formation, incisions were made in the
third interdigital zone along digit III and IV of St. 28–30 hindlimb
as previously described (Omi and Ide, 1996), and embryos were
harvested 4 days later. For cartilage graft preparation, the sternal
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chondrium and thoracic muscles. A piece of the cartilage (approxi-
mately 400 µm diameter) was implanted into St. 19–22 host distal
limb. Ectoderm removal was performed as previously described
(Yang and Niswander, 1995). To prevent myogenic cell migration
into the limb bud, after making a slit along the proximal margin of
the presumptive hindlimb level somatopleura of St. 16–17 embryo,
a piece of Nuclepore Membrane (pore size 0.2 µm; Whatman) was
inserted between the intermediate mesoderm and somatopleural
mesoderm. Cartilage-grafted, ectoderm-removed and barrier-
inserted limbs were ﬁxed when their contralateral control limbs
reached St. 26, 31 and 26–27, respectively.Local applications of proteins
Afﬁ-Gel Blue Gel agarose beads (Bio-Rad) were washed (Storm
and Kingsley, 1999) and soaked in 0.1% BSA in PBS containing 700 µg/
ml recombinant mouse Noggin/Fc chimera (R&D systems), 1 mg/ml
recombinant human BMP-2 (R&D systems) or 2 mg/ml recombinant
mouse sFRP-2 (R&D systems) and incubated on ice. 0.1% BSA in PBS-
soaked beads were used as negative controls. A Noggin-soaked bead
was grafted to interdigit II of St. 28–29 hindlimb. The embryos were
harvested 24 h after grafting. For BMP-2 bead grafts, to minimize
injury to the ectoderm, a shallow hole was made with a needle on
the dorsal side of a St. 26–27 metatarsal III proximal tip, and a bead
was grafted. The embryos were harvested 10 h after grafting. For
sFRP-2 bead grafts, a shallow hole was made on the dorsal side of aFig. 1. Six2 is expressed in the distal tendon precursor and tendon. (A) Six2 expression in
(arrowhead), zeugopod (black arrows) and pelvic region (white arrow). (B) Autopoda
mesenchyme. Anterior is on the left, dorsal is on the top. (B′) High magniﬁcation observa
(C) Six2 expression at the anterior/posterior edges of dorsal/ventral muscle masses (arrow
(D) Comparison of Six2 (ISH, magenta) and Pax7 (immunoﬂuorescence, green) expressio
both Pax7-negative mesenchymal cells (arrowheads) and Pax7-positive muscle precurso
in the same view as (D). (F) Six2 expression in the hindlimb at St. 30 and 36. At St. 30, Six
the dorsal tissues connected to the zeugopodal extensor muscles (EDL, yellow arrows; E
arrowheads). In addition, Six2 expression was observed in the ventral tissues connecte
digitorum longus; EHL, extensor hallucis longus; EB3, extensor brevis digiti III; AB2, ab
digitorum longus (Baumel et al., 1993). (For interpretation of the references to color inSt. 24–25 autopod, and a bead was grafted. The embryos were
harvested 24 h after grafting.Gene misexpression
Chicken Wnt6 Coding DNA Sequence (CDS) (DDBJ accession no.
AB199733) was isolated by PCR and 3′ RACE by referring to the
chicken genome database sequence (see Suppl. Data for the
sequence of PCR primers). Mouse Wnt3 CDS was isolated by PCR
by referring to the NCBI sequence (NM_009521). The sequences
around the ﬁrst ATG codons of cWnt6, mWnt3 and cHoxa-13 full
CDSs were modiﬁed to be NcoI-compatible sequences by PCR, and
then each CDS was connected to the NcoI site of the internal
ribosomal entry site (IRES) of pCITE or pCITE2a (Novagen). IRES-
CDS fragments was inserted to the ClaI site of RCAS-BP(A). RCAS-
mWnt3a and RCAS-mWnt7a were previously described (Kengaku
et al., 1998). These plasmids were used to transfect chicken
embryonic ﬁbroblasts (CEF) by lipofection. CEF culture, collection
and concentration of culture media were performed following
Yokouchi et al. (1995a). RCAS-IRES-cHoxa-13 was injected into the
presumptive hindlimb region of St. 9–12 embryos (Yokouchi et al.,
1995a), and embryos were ﬁxed when their contralateral limb
reached St. 26–27. Each of Wnt viruses or a mixture of RCAS-
mWnt3a and RCAS-IRES-cHoxa-13 was injected into St. 18–20
hindlimb buds, and the embryos were ﬁxed when control limbs
reached St. 29–30. pCAGGS constructions and electroporation
were performed as described in the caption of Suppl. Fig. 7.the chicken hindlimb. From St. 24 to St. 27–28, Six2 was expressed in the autopod
l cross-section of St. 26 hindlimb. Six2 was expressed in the dorsal and ventral
tion, ecto.: dorsal ectoderm. ((C)–(E)) Zeugopodal cross-sections of St. 26 hindlimb.
s), and in the muscle masses themselves. Anterior is on the left, dorsal is on the top.
n at the posterior edge of the dorsal muscle mass. Six2 expression was detected in
r cells (arrows). (E) Six2 expression (magenta) and nuclei (stained with DAPI, green)
2 expression was extended distally along the digits. At St. 36, Six2 was expressed in
HL, red arrowheads) and to the autopodal muscles (EB3, white arrows; AB2, white
d to the zeugopodal ﬂexor muscles (FPs, FPPs, FDL). Abbreviations: EDL, extensor
ductor digiti II; FP, ﬂexor perforates; FPP, ﬂexor perforans et perforates; FDL, ﬂexor
this ﬁgure legend, the reader is referred to the web version of this article.)
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Six2 is a marker of the limb tendon precursor and differentiated
tendon
In chick hindlimb, Six2 mRNA was ﬁrst detected at St. 23–24
in the posterior region of the presumptive autopod, in the
presumptive zeugopod and in the pelvic region (Fig. 1A). From
St. 24 to 28, the autopodal expression domain expanded ante-
riorly (Fig. 1A, arrowhead). Autopodal expression was restricted
to the sub-ectodermal mesenchyme on both dorsal and ventral
sides (Fig. 1B, B′) but not observed in the mesenchyme adjacent
to the AER (apical ectodermal ridge) (Fig. 1A and B). In theFig. 2. Comparison of expression of Six2 and tendon-related genes and Hoxa-13 in the ch
32 embryo. The Six2 expression patternwas identical to that of Tenomodulin. ((B) and (C))
and Scx showed overlapping expression in the metatarsal region (arrowheads) and in t
sections of St. 26 hindlimb. Autopodal expression of Six2 and Hoxa-13 was overlapping, an
ﬁbula; t, tarsal; mt, metatarsal. Proximal is on the left, dorsal is on the top.zeugopod, two linear expression domains were observed from
St. 25 to 28 (Fig. 1A, black arrows). When examined in cross-
section, these Six2 expression domains were found to be at the
anterior/posterior edges of the dorsal/ventral muscle masses
(Fig. 1C, arrows). In addition, weak expression was observed in
the muscle masses themselves (Fig. 1C). At the anterior/poster-
ior edges of muscle masses, Six2 was expressed in both Pax7-
positive and Pax7-negative cells (Fig. 1D and E), indicating that
Six2 was expressed in both muscle precursor cells and mesench-
ymal cells in the limb. At St. 30, autopodal Six2 expression
extended distally along the digits but never observed in the
interdigital mesenchyme (Fig. 1F). Finally, at St. 36, Six2 expres-
sion was observed in the tissues connected to the distal dorsalick hindlimb. (A) Expression of Six2 (right limb) and Tenomodulin (left limb) in a St.
Expression of Six2 (right limbs) and Scx (left limbs) at St. 26–27 (B) or St. 30 (C). Six2
he zeugopod (arrows). (D) Expression of PG-H, Six2 and Hoxa-13 in serial sagittal-
d shared the same proximal boundary (arrows) at the autopod-zeugopod border. ﬁ,
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for abbreviations), EHL (red arrowheads), EB3 (white arrow) and
AB2 (white arrowhead). Six2 was also expressed in the tissues
connected to the distal ventral muscles, including FPs, FPPs and
FDL (Fig. 1F). On the ventral side of the digits, Six2 expression
domains were bifurcated at the digital joints (Fig. 1F). This
morphology is typical of the tendon insertions of the “perforatus
(perforated)” muscles: e.g., FPs and FPPs (Baumel et al., 1993). A
similar expression proﬁle was observed in the chick forelimb
(Suppl. Fig. 1). The morphological features of the Six2 expressionFig. 3. Limb cartilage induces mesenchymal Six2 expression on the dorsal/ventral sid
Arrowheads indicate the most newly formed cartilage (PG-H) and the fronts of the ex
mesenchymal Six2 expression at the dorsal/ventral side. (B) Contralateral limb of (C). (C)
in interdigit III. ((C′) and (D)) High magniﬁcation observations of the limb shown in (C)
arrows). (D) At the ventral side, a linear Six2 expression domain (black arrows) was bifu
Dorsal linear expression, white arrow; ventral linear expression, black arrow; bifurcatio
limb induced ectopic Six2 expression. (F) Six2 expression in the contralateral limb of (G). (
the graft (asterisk). (H) Cross-section of the limb shown in (G). Ectopic Six2 expression (a
the dorsal ectoderm.domains observed at St. 36 suggest the possibility that Six2
labels the limb tendons.
Tenomodulin is a marker of the differentiated tendon (Shuk
unami et al., 2006). At St. 32, the Six2 expression pattern was
identical to that of the Tenomodulin (Fig. 2A), indicating that Six2 is
speciﬁcally expressed in the differentiated tendon. We then
compared Six2 expression to that of Scx, a marker of the tendon
precursor and tendon (Schweitzer et al., 2001). After St. 26, Six2
expression overlapped that of Scx in the metatarsal region and in
the zeugopod (arrowheads and arrows in Fig. 2B and C,e. (A) Expression of PG-H and Six2 compared in the hindlimb from St. 25 to 30.
panded expression domains (Six2). ((B)–(E)) Interdigital ectopic cartilage induced
Six2 expression in the hindlimb in which an ectopic digit (asterisk) had been formed
. (C′) Dorsal side of the ectopic digit. Six2 was expressed in a linear domain (white
rcated at the joints (arrowheads). (E) Cross-section of the digits shown in C′ and D.
n of ventral expression, arrowheads. ((F)–(H)) Sternal cartilage graft into the distal
G) In the sternal cartilage-grafted limb, ectopic Six2 expressionwas detected around
rrows) was restricted to the region between the graft (asterisk and dotted line) and
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expression domain of Six2 was less expanded distally than that of
Scx (arrowheads in Fig. 2B and C). The overlapping expression of
Six2 and Scx indicates that Six2 is also a marker for the tendon
precursor in chick limb after St. 26. We therefore next analyzed the
mechanism controlling limb tendon precursor formation by focus-
ing on the regulation of Six2 expression.Cartilage and BMP antagonist induce mesenchymal Six2 expression
Autopodal cartilage formation progresses in the proximal-to-
distal and posterior-to-anterior sequences. Extension of the autop-
odal Six2 expression domain followed autopodal cartilage forma-
tion (Fig. 3A), suggesting that the limb cartilage may induce Six2
expression in the neighboring mesenchyme. To test this possibility,
we examined the effect of ectopically formed or grafted cartilage
on Six2 expression.
After making incisions between digits and interdigital tissue,
ectopic digits with phalangeal cartilage are formed from the
residual interdigital mesenchyme (Omi and Ide, 1996) (Fig. 3B
and C). In the ectopic digits, Six2 was expressed between the
ectoderm and the phalangeal cartilage (Fig. 3C′, D, n¼11/14). The
Six2 expression domains in the ectopic digit had morphological
features very similar to those of normal digit. The dorsal ectopic
expression domain was a single linear domain (Fig. 3C′, E, white
arrows), and on the ventral side, a single linear expression domain
(Fig. 3D and E, black arrows) was bifurcated at the digital joints
(Fig. 3D and E, arrowheads).
We then analyzed whether the effect of cartilage in Six2
induction is direct. For this purpose, we grafted a piece of sternum
cartilage into the limb. In the grafted limbs, ectopic Six2 expressionFig. 4. BMP, BMP antagonist and the dorsal ectoderm regulate Six2 expression. (A) Loca
interdigit II, ectopic mesenchymal Six2 expression was observed (arrowheads) at 24 h aft
expression at 10 h after grafting of a BSA - or 1 mg/ml BMP-2 bead. Six2 expression was r
Six2 expression. Six2 expression in the hindlimb in which the dorsal ectoderm of digit III h
not detected (arrowhead). (D) Local application of the potent Wnt inhibitor sFRP-2 repr
sFRP-2-soaked bead grafting. Six2 expression was repressed around the sFRP-2 bead.was observed around the graft (Fig.3F and G, n¼3/4). The ectopic
Six2 expression was restricted to the mesenchyme located
between the graft and dorsal ectoderm (Fig. 3H). These results
suggest that the cartilage induces mesenchymal Six2 expression
via diffusible factor(s).
A BMP antagonist, Noggin, is expressed in the cartilage (Brunet
et al., 1998; Capdevila and Johnson, 1998; Merino et al., 1998; Pathi
et al., 1999). We examined the possibility that Noggin can induce
Six2 expression. As shown in Fig. 4A, local application of Noggin
with Noggin-soaked beads resulted in ectopic Six2 induction in the
interdigital mesenchyme around the bead (n¼6/6). Next we tested
BMP function by grafting a bead soaked in BMP-2 solution into the
dorsal side of the metatarsal III proximal tip, where Six2 is
expressed. At 10 h after grafting, Six2 expression disappeared
around 1 mg/ml BMP-2-soaked bead (Fig. 4B, n¼5/7).
Administration of BMP is known to induce apoptosis of limb
bud mesenchyme cells. However, at 10 h after grafting, we did not
observe an increase in cell death around the grafted bead soaked
with 1 mg/ml BMP-2 solution (Suppl. Fig. 2), suggesting that the
observed disappearance of Six2 expression is not due to apoptosis.
Therefore, our results indicate that BMP represses Six2 expression,
and that cartilage expressing Noggin induces mesenchymal Six2
expression in the limb by antagonizing BMP signaling.Ectoderm and Wnts are positive regulators of Six2 expression
Mesenchymal Six2 expression was always found between the
cartilage and the ectoderm, indicating that limb ectoderm may be
involved in regulating Six2 expression. To test this possibility, we
examined Six2 expression after the partial removal of the limb
ectoderm. As shown in Fig. 4C, surgical removal of the dorsall application of Noggin induced ectopic Six2 expression. In the Noggin bead-grafted
er grafting. (B) Local application of BMP repressed endogenous Six2 expression. Six2
epressed around the BMP-2 bead. (C) Dorsal ectoderm is essential for mesenchymal
ad been removed surgically. In the region of ectoderm removal, Six2 expression was
esses endogenous Six2 expression. Six2 expression at 24 h after a BSA- or 2 mg/ml
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mesenchyme (n¼2/2). Similarly, ventral ectoderm removal
resulted in the loss of ventral Six2 expression (n¼2/2. data not
shown). These results indicate that limb ectoderm is required for
the mesenchymal Six2 expression.
Members of the Wnt gene family, including Wnt6 (Geetha-
Loganathan et al., 2005; Geetha-Loganathan et al., 2010;
Rodriguez-Niedenfuhr et al., 2003), Wnt7a (Dealy et al., 1993)
and Wnt3 (Suppl. Fig. 3) are speciﬁcally expressed in the limb
ectoderm. In order to test the possibility that Wnts are involved in
the regulation of Six2 expression in the limb, we analyzed the
effect of local application of a secreted Frizzled-related protein,
sFRP-2. sFRP-2 is a potent inhibitor of Wnts, including Wnt6 and
Wnt7a (Amura et al., 2005; Yoshioka et al., 2012). As shown in
Fig. 4D, grafting of sFRP-2-soaked beads resulted in the repression
of autopodal Six2 expression (n¼8/11), and we did not observe an
increase in cell death around the bead soaked with sFRP-2 (Suppl.
Fig. 2), suggesting that ectodermal Wnts are positive regulators of
Six2 expression.
To ascertain whether ectodermal Wnts function as positive
regulators of Six2 expression, we misexpressed Wnt3a via
replication-competent retrovirus vector RCAS-BP(A) (Petropoulos
and Hughes, 1991). In the non-infected contralateral autopods at
St. 30, metatarsal cartilage formed normally (Fig. 5A), and no
change in Noggin expression was observed (data not shown). Six2
expression in the dorsal/ventral mesenchyme and muscle masses
was also unaffected (Fig. 5A). In contrast, in the RCAS-Wnt3a-
injected limbs, cartilage was completely lost (Fig. 5B), and Noggin
expression was never observed (data not shown). For this reason,
it was difﬁcult to distinguish the autopod from the zeugopod
based on anatomical features of cartilage. Therefore, we discrimi-
nated between these two compartments using autopod-speciﬁc
Hoxa-13 expression as an indicator (Fig. 5B and C). In the Wnt3a-
misexpressing autopods, Six2 was expressed in the muscle mass
and in the entire mesenchyme, except cells adjacent to the AER
(Fig. 5B, blue arrow, n¼5/5). In contrast to the results for the
autopods, in the Wnt3a-misexpressing zeugopods, Six2 expression
was never detected in the mesenchyme and was restricted to the
muscle precursor cells (Fig. 5C, n¼5/5). Similar to misexpression ofFig. 5. Wnt3a, a model of ectodermal Wnts, induces ectopic Six2 expression. In serial cro
(B) and RCAS-Wnt3a-injected zeugopod (C), mRNAs were detected by ISH. Dorsal is on t
interpretation of the references to color in this ﬁgure legend, the reader is referred to tWnt3a, viral misexpression of Wnt6, Wnt7a, and Wnt3 caused
partial loss of the autopodal cartilage and ectopic Six2 expression
in an area located far from the ectoderm in the autopod (Suppl.
Fig. 4). These results indicate that Wnt signaling can activate Six2
expression.
Interestingly, in the RCAS-Wnt3a-injected limbs, ectopic Six2
expression occurred in the autopodal mesenchyme, despite the
absence of cartilage and an unaltered Bmp expression level (Suppl.
Fig. 5), but never in the zeugopodal mesenchyme. The different
responses of the autopod and zeugopod allow us to hypothesize that
autopod-speciﬁc factor(s), besides Noggin, cancel(s) BMP signaling to
activate Six2 expression. Since Hoxa-13 and Hoxd-13 were likely
candidates for the autopod-speciﬁc factors, we analyzed the effects
of Hoxa-13/Hoxd-13 on Six2 expression.Hoxa-13/Hoxd-13 misexpression induce ectopic Six2 expression in the
zeugopodal mesenchyme located far from cartilage
Prior to the functional analysis of autopodal Hox genes, we
compared the expression of Six2 and the Hox genes in the autopod.
As shown in Fig. 2D and Suppl. Fig. 6, Six2 and Hoxa-13 expression
were overlapping, and the expression domains of these two genes
shared the same proximal expression boundary. In addition, the
Six2 expression domain was partially overlapping with that of
Hoxd-13 in the distal autopod (Suppl. Fig. 6).
In order to analyze autopodal Hox gene function(s) in the
regulation of Six2 expression, Hoxa-13 was misexpressed in the
limb mesenchyme using RCAS-IRES-Hoxa-13. In the Hoxa-13-mis-
expressing limbs at St. 26–27, autopodal Six2 expression was not
affected (Fig. 6A, n¼0/17). On the other hand, in the zeugopods,
ectopic Six2 expression was observed (Fig. 6A, arrows, n¼9/17). In
the contralateral control zeugopods, Six2 expression was restricted
to the muscle mass and to the mesenchyme adjacent to the edges
of the muscle mass (Fig. 6B). In the Hoxa-13-misexpressing
zeugopods, ectopic Six2 expression was found in the area located
between the muscle mass and the ectoderm (Fig. 6B, blue arrows).
This zeugopodal ectopic Six2 expression was also caused by sub-
ectodermal introduction of pCAGGS-Hoxa-13 or -Hoxd-13 usingss-sections of the contralateral control autopod (A), RCAS-Wnt3a-injected autopod
he top. Posterior is on the left in (A), and anterior is on the left in (B) and (C). (For
he web version of this article.)
Fig. 6. Hoxa-13 misexpression results in ectopic Six2 expression in the zeugopodal
mesenchyme. (A) Six2 expression in the contralateral control and RCAS-IRES-Hoxa-13-
injected hindlimb. Ectopic Six2 expressionwas observed in the zeugopod (arrows). (B) In
serial cross-sections of zeugopods of St. 26 control limb, RCAS-IRES-Hoxa-13-injected
limb, muscleless limb and RCAS-IRES-Hoxa-13-injected muscleless limb, mRNAs were
detected using ISH. Ectopic Six2 expression in the mesenchyme is indicated with the
blue and green arrows. Six2 expression in themuscleless limb is indicated with the black
arrows. ((C)–(G)) mRNA expression in serial cross-sections of Hoxa-13-misexpressing
zeugopod ((C), (D), (F) and (G)) or autopod (E). ((C) and (D)) Between the muscle masses
and ventral ectoderm of the anterior-ventral zeugopod, ectopic expression of Six2, but
not endogenous Hoxa-13 expression, was detected (arrows). (E) Endogenous autopodal
Hoxa-13 expression in the same limb as in (D). (F) In this Hoxa-13-misexpressing
zeugopod, two ectopic cartilages were observed (arrow and arrowhead). (G) Section
adjacent to that in (F). The dorsal ectopic cartilage expressed Noggin (arrow), but the
ventral one did not (arrowhead). Noggin expression level in the tibia and ﬁbula was
similar to that in the contralateral zeugopod (data not shown). Anterior is on the left and
dorsal is on the top in (B)–(G). (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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functions for Hoxa-13 and Hoxd-13.
There are two possible explanations for the ectopic Six2 expres-
sion in Hoxa-13/Hoxd-13-misexpressing zeugopods. One is that Six2
misexpression was induced in the zeugopodal mesenchyme itself,
and the other is migration of the Six2-expressing autopodal
mesenchymal cells into the zeugopod. To discriminate between
these possibilities, we detected endogenous Hoxa-13-expressing
cells using a Hoxa-13 3′ UTR probe to mark the original autopodal
mesenchymal cells. As shown in Fig. 6C and D, in the Hoxa-13-
misexpressing zeugopod, ectopic Six2-expressing cells, located
between the ventral muscle mass and ectoderm (Fig. 6C, arrow),
did not express endogenous Hoxa-13 (Fig. 6D, arrow). Endogenous
Hoxa-13 expression was detected only in the autopodal mesench-
yme of the same limb (Fig. 6E). These observations indicate that the
induced zeugopodal Six2 expression is not due to the migration of
Six2-expressing cells from the autopod, but rather it is due to de
novo expression resulting from misexpressed Hoxa-13.
Hoxa-13 is expressed not only in the autopodal mesenchyme
but also in restricted parts of the muscle masses in developing
limb (Yamamoto et al., 1998). Thus, the induction of ectopic Six2
expression in Hoxa-13-misexpressing limbs may reﬂect two dis-
tinct Hoxa-13 functions-one in the autopodal mesenchyme and the
other in the muscle mass. To test the possibility that Hoxa-13-
misexpressing muscle mass interacts with the zeugopodal
mesenchyme to induce ectopic Six2 expression, Hoxa-13 was
misexpressed in the muscleless limb buds. To prevent muscle
precursor cell migration from somites to limb bud, we inserted a
piece of Nuclepore membrane between the hindlimb-level soma-
topleural mesoderm and intermediate mesoderm prior to the
migration. In the manipulated limbs, cartilage developed normally
(our observation), but the dorsal and ventral muscle masses were
completely absent (Fig. 6B). Six2 expression was not changed in
the autopod of the muscleless limb (data not shown), and
zeugopodal Six2 expression remained in the central regions of
the dorsal and ventral mesenchyme (Fig. 6B, black arrows, n¼2/2),
suggesting that zeugopodal Six2 expression is not dependent on
interaction with the muscle mass. We then misexpressed Hoxa-13
in the muscleless limb buds and found that ectopic Six2 expression
was also detectable in the zeugopodal mesenchyme adjacent to
ectoderm (Fig. 6B, green arrows, n¼2/2). These results indicate
that Hoxa-13 affects mesenchymal Six2 expression in a muscle
mass-independent manner.
In the Hoxa-13-misexpressing zeugopod, ectopic cartilages develop
between two long bone cartilages (Yokouchi et al., 1995a). It is
therefore possible that Hoxa-13 up-regulates Six2 expression by
increasing Noggin level through ectopic cartilage formation. To test
this possibility, we analyzed Noggin expression in the Hoxa-13-
misexpressing zeugopods. In the Hoxa-13-misexpressing hindlimb,
Noggin mRNA levels in the tibia and ﬁbula were unaltered (Fig. 6G
and data not shown). In this zeugopod, two ectopic cartilages were
formed (Fig. 6F, arrow and arrowhead). The dorsal cartilage (Fig. 6G,
arrow), but not the ventral cartilage (arrowhead), expressed Noggin. In
this zeugopod, ectopic Six2 expression was observed in the mesench-
yme located between the ventral muscle mass and the ectoderm
(Fig. 6C, arrow), in spite of the long distance from the Noggin-
expressing dorsal ectopic cartilage. This result suggests that Hoxa-13
can up-regulate Six2 expression without increasing the Noggin
expression level.
Wnt3a/Hoxa-13 co-misexpression cooperatively induces ectopic Six2
expression in the zeugopodal mesenchyme
As already shown in Fig. 6B, ectopic Six2 induction by Hoxa-13
misexpression was restricted to the mesenchyme near the ecto-
derm. We then tested the possibility that Hoxa-13 cooperates with
Fig. 7. Co-misexpression ofWnt3a and Hoxa-13 induces ectopic Six2 expression in the zeugopodal mesenchyme distant from the ectoderm. Expression of PG-H, Six2 and Pax7
in serial cross-sections of a zeugopod from an RCAS-Wnt3a/RCAS-IRES-Hoxa-13 co-injected limb. Six2 was ectopically expressed in the mesenchyme located far from the
ectoderm (arrowheads). Anterior is on the left, dorsal is on the top.
Fig. 8. Six2 expression in Hox mutant mouse embryos. (A) Six2 expression in wildtype, Hoxa-13þ /−;HoxDdel/del, Hoxa-13−/−;HoxDþ /del or Hoxa-13−/−;HoxDdel/del forelimb at
11.5 dpc. Dorsal views. ((B) and (C)) Cross-sections of autopods shown in (A). Dorsal is on the top in (B) and (C).
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Wnt3a/Hoxa-13 co-misexpressing limb. For the co-misexpression
of Wnt3a/Hoxa-13, we injected a mixture of two viruses, RCAS-
Wnt3a and RCAS-IRES-Hoxa-13. Interestingly, in the co-injected
limb, ectopic Six2 expression was reproducibly observed in
mesenchyme located not only in the sub-ectodermal region but
also in the central region of the limb (Fig. 7, arrowheads, n¼3/3).
As already shown, RCAS-Wnt3a alone did not induce any ectopic
Six2 expression in the zeugopod (Fig. 5C), and RCAS-IRES-Hoxa-13
alone induced ectopic Six2 expression only in the sub-ectodermal
region (Fig. 6B). Thus, co-misexpressed Wnt3a enhanced the
misexpressed Hoxa-13 function in the induction of Six2 expression.
These results indicate that Hoxa-13 cooperates with ectodermal
Wnts in the regulation of Six2 expression.
Six2 expression in the dorsal autopod disappears in Hoxa-13−/−;
HoxDdel/del mice
We showed that misexpression of Hoxa-13 induces ectopic Six2
expression. To ask whether autopodal Hox expression is necessary
for autopodal Six2 expression, we analyzed Six2 expression in Hox
mutant mice. For cartilage formation, Hoxa-13 and HoxD Abd-B
family genes show functional redundancy (Fromental-Ramain
et al., 1996; Zakany et al., 1997). Therefore, it is possible that these
Hox genes also redundantly regulate Six2 expression. To test this
possibility, we used mice doubly mutant for Hoxa-13 and HoxD
alleles for functional analysis. HoxDdel is a triple loss-of-function
allele of Hoxd-13, Hoxd-12 and Hoxd-11 (Zakany et al., 1997).
As in the chicken limb bud, in the mouse forelimb bud,
autopodal Six2 expression expanded from posterior to anterior
on both dorsal and ventral sides (Suppl. Fig. 8). In the Hoxa-13þ /−;
HoxDdel/del or Hoxa-13−/−;HoxDþ /del autopods at 11.5 dpc (days
post-coitum), Six2 expression was not affected (Fig. 8A, n¼2/2 in
each of these genotypes). In contrast, as shown in Fig. 8A and C,
Six2 expression on the dorsal side of the autopod was not detected
in Hoxa-13−/−;HoxDdel/del mice (n¼2/2). Conversely, ventral autop-
odal Six2 expression was not signiﬁcantly affected (Fig. 8B and C).
In the Hoxa-13−/−;HoxDdel/del embryos, facial expression of Six2was not affected (Suppl. Fig. 9), indicating that the loss of Six2
expression is speciﬁc to the dorsal autopod.
Does the loss of BMP antagonist expression cause the dorsal
loss of Six2 expression in the Hoxa-13−/−;HoxDdel/del embryo? To
answer this question, we analyzed the expression of BMP antago-
nists in the Hoxa-13−/−;HoxDdel/del embryo. The expression levels
of Noggin and Gremlin, which encodes another BMP antagonist,
were not changed in the Hoxa-13−/−;HoxDdel/del autopod at
11.5 dpc (Suppl. Fig. 10). Thus, at least the dorsal loss of Six2
expression in the Hoxa-13−/−;HoxDdel/del embryo is not a result of
an increase in BMP signal.Discussion
Tendons develop in the sub-ectodermal region adjacent to
cartilage that has formed earlier, suggesting that the ectoderm
and cartilage induce tendon formation through secreted molecules
determining the differentiation fate of limb mesenchymal cells.
Moreover, tendons develop in a position-speciﬁc pattern, suggest-
ing that the mechanism that determines the position-speciﬁc
tissue patterning functions concurrently. We found that Six2 is
expressed in the tendon precursor and tendon in the limb. Then
we tried to identify the factors that induce Six2 expression in the
tendon precursor and determine its position-speciﬁc pattern in the
autopod.
Cartilage and ectoderm regulate mesenchymal Six2 expression in the
distal limb tendon precursor via tissue interactions
In order to analyze the tissue interaction inducing the autopo-
dal tendon precursor, we examined the signaling molecules
affecting Six2 expression. Six2 is expressed in the mesenchyme at
the dorsal and ventral side of the cartilage, and never expressed in
the mesenchyme adjacent to the AER or the interdigital mesench-
yme (Fig. 1A, B and F). BMPs, candidate signaling molecules for the
control of Six2 expression, are expressed in both AER and the
interdigital mesenchyme (Francis et al., 1994; Macias et al., 1997;
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(Brunet et al., 1998; Capdevila and Johnson, 1998; Merino et al.,
1998; Pathi et al., 1999). We showed that local application of BMP-
2 represses Six2 expression (Fig. 4B) and that Noggin induces
ectopic Six2 expression (Fig. 4A). Moreover, we showed the
necessity of the limb ectoderm for underlying Six2 expression
(Fig. 4C). Hence, cartilage-derived Noggin would restrict Six2
expression in the sub-ectodermal mesenchyme adjacent to the
cartilages by antagonizing BMP activity. Scx expression is also
regulated by BMP, Noggin and the ectodermal signal in the limb
bud (Schweitzer et al., 2001). In the limb tendon precursor, the Scx
expression domain is wider than that of Six2 (Fig. 2B and C). These
ﬁndings suggest that Scx and Six2 mark tendon precursor cells at
distinct stages of differentiation. On the other hand, at an earlier
developmental stage, Scx is not expressed in the mesenchyme of
the posterior distal limb bud (Suppl. Fig. 11). In contrast, Six2, as
well as other tendon/ligament-related genes including Irxl1/Mkx,
are expressed in this region (Suppl. Fig. 11; Takeuchi and Bruneau,
2007). This suggests the possibility that this posterior distal
mesenchyme also contributes to tendon/ligament cell fate. In
addition, non-overlapping expression of Scx and Six2 at an early
stage suggests that these genes are regulated independently in the
posterior distal mesenchyme.
The presence of ectoderm-derived signaling molecules respon-
sible for tendon precursor-speciﬁc gene expression regulation has
been proposed (Schweitzer et al., 2001), but such a molecule has
not been identiﬁed previously. We showed that application of a
Wnt antagonist represses Six2 expression (Fig. 4D) and that
misexpression of Wnt induces Six2 expression in the center of
the autopod (Fig. 5B and Suppl. Fig. 4) without reducing the Bmp
expression level (Suppl. Fig. 5). Therefore, mesenchymal cells
require not only cartilage expressing Noggin but also ectodermal
Wnts for Six2 expression. Considering expression in the limb bud,
ectodermal Wnt6 and Wnt7a may mainly function in Six2-expres-
sing tendon precursor formation in the chick limb. Recently, it was
reported that loss of function of Wntless and beta-catenin both
cause the loss of Scx expression in the limb tendon precursor (Zhu
et al., 2012). Wntless is required for the secretion of various Wnts,
and beta-catenin is a crucial mediator of the canonical Wnt
pathway. This report supports our ﬁnding that ectodermal Wnts
are involved in limb tendon precursor-speciﬁc gene regulation.
Hoxa-13 and Hoxd-13 regulate autopodal Six2 expression in
cooperation with Noggin and Wnts from cartilage and ectoderm
In the Wnt3a-misexpressing limb, ectopic Six2 expression was
restricted to the autopod (Fig. 5), suggesting the involvement of
autopod-speciﬁc factor(s) in the regulation of Six2 expression.
Therefore, it is possible that autopodal Hox genes regulate Six2
expression in the tendon precursor. To answer the question of
whether Hox genes are involved in tendon precursor formation,
we analyzed the function of Hox genes expressed speciﬁcally in the
autopodal mesenchyme. We showed that misexpression of either
Hoxa-13 or Hoxd-13 in the zeugopodal mesenchyme results in
ectopic Six2 expression (Fig. 6A and B; Suppl. Fig. 7). In addition,
dorsal Six2 expression disappeared in the Hoxa-13−/−;HoxDdel/del
autopod (Fig. 8). These results indicate that autopodal Hox genes
regulate Six2 expression in the tendon precursor. Furthermore, our
results point to the possibility that Hox genes control position-
speciﬁc tendon precursor formation via the regulation of tendon
cell fate-speciﬁc gene expression.
In the Hoxa-13-misexpressing limb, ectopic Six2 expression was
restricted to the mesenchyme near the ectoderm (Fig. 6B), suggest-
ing the necessity of ectodermal factor(s) for Hox function. To ask
about the possible cooperation between autopodal Hox genes and
ectodermal Wnt, Wnt3a/Hoxa-13 co-misexpression was performed,and the enhanced ectopic Six2 expression resulted in the zeugopod
(Fig. 7). This result indicates the cooperation of autopodal Hox and
ectodermal Wnt in the Six2 expression regulation.
In the Hoxa-13-misexpressing limb, ectopic Six2 expression was
restricted to the mesenchyme far from the cartilage (Fig. 6B and C),
where Noggin level is low. Additionally, in the Wnt3a-misexpres-
sing autopod and in the Wnt3a/Hoxa-13-co-misexpressing zeugo-
pod, Six2 is ectopically expressed in the mesenchyme (Fig. 5B and
Fig. 7), where Noggin level is low due to the loss of cartilage. These
ﬁndings suggest the possibility that autopodal Hox genes can
activate Six2 expression despite the low level of Noggin. Interest-
ingly, dorsal Six2 expression was lost in the Hoxa-13−/−;HoxDdel/del
autopod, but ventral expression was not affected (Fig. 8). Bmp-4
expression in dorsal mesenchyme is more intensive than that in
ventral mesenchyme in the chicken limb bud (Geetha-Loganathan
et al., 2006), suggesting higher BMP concentration in the dorsal
mesenchyme than in the ventral mesenchyme. Therefore, autopo-
dal Hox genes may function to override a certain level of BMP
signaling to permit autopodal Six2 expression. Although Hoxa-13 is
expressed in the entire autopodal mesenchyme, Six2 is never
expressed in the interdigital mesenchyme or the mesenchyme
adjacent to the AER in normal limbs or even in Wnt3a-misexpres-
sing limbs (Fig. 1A, B, and F; Fig. 5B), where the BMP level is high.
In addition, misexpression of Hoxa-13 and co-misexpression of
Wnt3a/Hoxa-13 did not induce ectopic Six2 expression in the sub-
AER mesenchyme (data not shown). Therefore, the autopodal Hox
genes alone are not sufﬁcient to permit Six2 expression in the
region that receives high level BMP signaling. It is also possible
that negative factors other than BMPs repress Six2 expression in
sub-AER mesenchyme, and AER-FGFs are candidates for these
negative factors. We tested the effect of AER-FGF, but contrary to
our expectation, Six2 expression was enhanced around grafted
FGF4-soaked beads (data not shown). Since an Wnt inhibitor, Dkk-
1, is expressed in the AER of chick and mouse (Grotewold and
Ruther, 2002), it is possible that input of Wnt signaling is not
enough to activate Six2 expression in the sub-AER mesenchyme
even in the presence of Hoxa-13 and Hoxd-13. Alternatively,
transcription factors speciﬁcally expressed in the sub-AER
mesenchyme, such as Msx1 (Yokouchi et al., 1991b), that have
activity antagonistic to Hoxa-13 and Hoxd-13 (Suzuki et al., 2003)
may be involved in the repression of Six2 expression in the sub-
AER region.
How do the autopodal Hox genes regulate Six2 expression? In the
autopod, the Six2 expression domain overlaps that of Hoxa-13, and
they share the same proximal boundary, suggesting that Hoxa-13may
regulate Six2 expression via a cell-autonomous mechanism or via a
very short-range intercellular signal. Six2 is a downstream target of
several Hox transcription factors. For instance, Hoxa-2 represses Six2
expression in the second branchial arch (Kutejova et al., 2008). In
addition, Hox11 (Hoxa-11, Hoxc-11 and Hoxd-11) directly bind to the
regulatory region upstream of the Six2 promoter by forming a complex
with Pax2 and Eya1 and activate Six2 expression in the metanephric
kidney (Gong et al., 2007; Yallowitz et al., 2009). Since the Hox11
binding sequence in this region is TTAT and this sequence is also the
target of other Abd-B family Hox proteins, including Hox13, it is likely
that Hox13 also control Six2 expression by binding this site. However,
interestingly, when the enhancer activity of this regulatory region was
analyzed in transgenic mice, expression of the reporter gene recapi-
tulated Six2 expression in the branchial arch, otic region, and urogen-
ital mesoderm, but not in the tendon precursor of the limb bud (Gong
et al., 2007). This indicates that Hox13-dependent Six2 enhancer
activity in the tendon precursor is independent from this region.
Alternatively, Hox13 bind to the same site as Hox11, but for transcrip-
tional activation, Hox13 interact with a yet unidentiﬁed tendon-
speciﬁc enhancer located elsewhere. Our transgenic mouse analysis
using a BAC clone encompassing a region 157 kb upstream and 41 kb
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same expression pattern as in the report by Gong et al. (2007) and
failed to recapitulate the tendon precursor expression (our unpub-
lished results). This indicates that the Hox13-dependent tendon
enhancer of Six2 is located far from the transcription start site.
Another possibility in the regulation of Six2 by Hox genes is that
they modulate the function(s) of receptor-regulated Smads (R-
Smads), the effectors of BMP and Tgf-beta/Activin signaling. Hoxa-
13 and Hoxd-13 interact with the MH2 domain of R-Smads,
including two BMP-regulated Smads, Smad5 and Smad1, and
antagonize Smad-mediated transcriptional activation (Williams
et al., 2005). It is possible that these molecular interactions found
in yeast and cultured mammalian cells explain the repression of
BMP signaling by Hoxa-13 and Hoxd-13 in Six2 regulation in the
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